Illumina Posts 3 Percent Revenue Decline for Q1, as Asia Sales Surge | GenomeWeb

NEW YORK (GenomeWeb News) – Just days after fending off an attempt by Roche to take control of its board of directors, Illumina reported after the close of the market Monday that its first-quarter revenues declined 3 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.